Progress in allogeneic hematopoietic stem cell transplantation in treatment of hematological malignancies
10.3760/cma.j.issn.1009-9921.2017.02.001
- VernacularTitle:异基因造血干细胞移植在血液肿瘤治疗中的研究进展
- Author:
Yingjun CHANG
;
Yuanyuan ZHANG
- Keywords:
Hematologic neoplasms;
Hematopoietic stem cell transplantation;
American Society of Hematology Annual Meeting
- From:
Journal of Leukemia & Lymphoma
2017;26(2):65-67,82
- CountryChina
- Language:Chinese
-
Abstract:
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a curable method for hematological malignancies.Nearly all transplant candidates have donor with the successful application of haploidentical SCT.This article summarized some reports on donor selection,prophylaxis and treatment of graft-versus-host disease,and graft failure in the 58th American Society of Hematology Annual Meeting to present the progress of allo-HSCT in treating hematological malignancies.
